Antiglycolipid antibodies in normal and pathologic human sera and synovial fluids.
Antiglycolipid antibodies were measured in normal and pathologic sera and synovial fluids by means of a modified microplate method of complement-mediated immune lysis of fluorescent dye-trapped liposomes. All sera of normal subjects had antibodies against globopentaosylceramide (IV3 GalNAcGbOse4Cer), ganglioside GM1, gangliotriaosylceramide, gangliotetraosylceramide, and galactosylneolactotetraosylceramide antigens. Most sera of normal subjects had antibodies against lactotriaosylceramide, N-glycolylneuraminosyl-neolactotetraosylceramide (NeuGcnLcOse4Cer), GM3 ganglioside with N-glycolylneuraminic acid (NeuGcGM3) and GD1a antigens. Differences of titers against IV3GalNAcGbOse4Cer, neolactotetraosylceramide, NeuGcGM3 and NeuGcnLcOse4Cer antigens were observed between sera of normal subjects and pathologic sera from cases of leukemias, lymphomas, several autoimmune diseases and liver diseases.
D000328:Adult; D001323:Autoantibodies / Q000032:analysis*; D003095:Collagen Diseases / Q000276:immunology; D003165:Complement System Proteins; D005260:Female; D005312:Fetal Blood / Q000276:immunology; D006017:Glycolipids / Q000276:immunology*; D006801:Humans; D007938:Leukemia / Q000276:immunology; D008081:Liposomes; D008107:Liver Diseases / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008223:Lymphoma / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011696:Purpura, Thrombocytopenic / Q000276:immunology; D013582:Synovial Fluid / Q000276:immunology*
D001323:Autoantibodies; D006017:Glycolipids; D008081:Liposomes; D003165:Complement System Proteins